The treatment involves medications, braces, physical therapies and extracorporeal shock wave therapy is a type of Non-surgical treatment. Pain in lateral epicondylitis (tennis elbow) is excruciating in severe conditions, which can be controlled by administering non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin and cortisone are administered to control pain in tennis elbow. Besides the medications, physical therapies such as ice massage or muscle stimulating techniques are utilized to improve healing. In addition, there are braces or strap available in the market, which limits the stress on elbow muscles and tendons. Moreover, extracorporeal shock wave therapy may be tried by a therapist that is intended to promote body’s natural healing process. Treatment sector comprises certain surgical procedures recommended for patients not responding to the non-surgical treatment for six to twelve months. Two surgical methods that are performed include open surgery and arthroscopic surgery.
Request to get the report sample pages at : https://www.blueweaveconsulting.com/lateral-epicondylitis-(tennis-elbow)-market-bwc20065/enquire-before-purchase
Increase in geriatric population base also contribute to the prevalence of lateral epicondylitis. The target disease is found to be more prevalent in geriatric population. With an upsurge in lifestyle disorders, the market is anticipated to register significant growth in near future. Moreover, favorable government initiatives such as Integrated Care for Older People to raise the awareness about geriatric health drives the demand for the market.
Tennis elbow is seen in older individuals and is more common in men than in women. Any activity that involves forceful turning of the hand or forceful extension of the wrist can produce tennis elbow. This condition is treated by resting the affected area, avoiding activities that cause pain, and wearing an elbow guard. The tennis elbow facilitates the gliding of muscles and tendons over bony surfaces. The most common joint affected by bursitis is the shoulder, although the elbow, foot, knee, and hand can be affected.
North America dominated the global tennis elbow treatment market in terms of revenue share in 2019. Increasing number of sport events & competitions in the U.S. coupled with increasing patient awareness level are the vital factors for the growth of tennis elbow treatment market in this region. Furthermore, factors such as rising geriatric population, and availability of insurance coverage are projected to drive the regional demand. The presence of leading key players headquarter amidst the region is the key factor driving growth of North America tennis elbow market across the global region. Braces (included in other segment) segment is expected to exhibit lucrative growth over the forecast period owing to the increasing incidence of sports injuries and growing geriatric population.
The global tennis elbow treatment market is consolidated in nature. Various companies are striving to gain market share by adopting competitive strategies such as joint ventures and research partnerships. Some key players operating in the market include Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex and other prominent players.